• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Neuropsychological adverse drug reactions of Remdesivir: analysis using VigiBase, the WHO global database of individual case safety reports
CONCLUSIONS: Our study demonstrates that remdesivir, a novel drug applied to the treatment of COVID-19, does not have a significant association with adverse neurologic or psychiatric reactions in the real-world setting.PMID:34919240 | DOI:10.26355/eurrev_202112_27435
Source: European Review for Medical and Pharmacological Sciences - December 17, 2021 Category: Drugs & Pharmacology Authors: S Lee J W Yang S Y Jung M S Kim D K Yon S W Lee H-C Kang E Dragioti K Tizaoui L Jacob A Koyanagi J-E Salem K Kostev A Lascu J I Shin J H Kim L Smith Source Type: research

Reduction in Neurological Disease Hospitalization Rate During Covid-19 Pandemic in Abruzzo
ConclusionsDespite the severity of the diseases included in MDC 1 (i.e. ischemic stroke, intracranial hemorrhage), a significant decline was detected in hospital admissions in Abruzzo. Subsequently, a high number of subjects might have not received the necessary health assistance leading to an increase in mortality and morbidity for these severe pathologies. Additionally, patients might have avoided seeking hospital care in response to the fear of contagion triggered either by media or as a result of the stay-at-home government recommendations.Key messagesAn alarming reduction in all types of hospitalizations for neurologi...
Source: The European Journal of Public Health - October 20, 2021 Category: General Medicine Source Type: research

Outcome after acute ischemic stroke treatment during Covid-19 outbreak in South-East Tuscany
CONCLUSION: During the lockdown period due to Covid-19 pandemic, patients with acute ischemic stroke had a worse prognosis. These findings suggest the need to improve the health system organization to guarantee an appropriate treatment during the pandemic, including the patients that are not affected by Covid-19.PMID:34579640 | DOI:10.2174/1871529X21666210927094058
Source: Cardiovascular and Hematological Disorders Drug Targets - September 28, 2021 Category: Drugs & Pharmacology Authors: Maurizio Acampa Valentina Peresso Pietro Enea Lazzerini Carlo Domenichelli Francesca Guideri Rossana Tassi Stefano Dami Roberto Marconi Giovanni Iannelli Giovanni Linoli Giulia Peppoloni Simone Nocentini Simone Gallerini Alessandra Cartocci Sandra Bracco Source Type: research

Pages: 1  2  3  4  5  6